Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion
2026-05-27
·
via Bloomberg Markets
Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion, leveraging its…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。